Il sistema renina-angiotensina-aldosterone, l'enzima di conversione dell'angiotensina I e gli ACE-inibitori. Prospettiva storica e recenti acquisizioni

Translated title of the contribution: The renin-angiotensin-aldosterone system, the angiotensin I converting enzyme and the ACE-inhibitors. Historical perspective and recent achievements

Gian Franco Gensini, Donatella Lippi, Andrea A. Conti

Research output: Contribution to journalArticle

Abstract

The renin-angiotensin-aldosterone system (RAAS) is committed to the regulation of circulatory homeostasis. This system, present in the majority of animal species, is constituted by several elements which behave as effectors able to increase their levels in response to the reduction of the intravascular volume and to the decrease of the renal perfusion. In turn, RAAS is regulated by a number of mechanisms. In our review a historical view precedes the description of the major functions of RAAS, i.e. the regulation of arterial pressure and the control of the hydroelectrolytic homeostasis. The evolution of the achievements about the angiotensin I converting enzyme is reviewed and the currently investigated relationship between RAAS and hemostatic system is assessed. The historical perspective of this review is useful to follow the key passages leading from clinical research to evidence-based therapeutic applications, in particular to the development of ACE-inhibitors. The evaluation of the rationale of ACE-inhibitors therapy in the treatment of arterial hypertension, acute myocardial infarction, heart failure, and diabetic nephropathy, and a discussion of the angiotensin receptor blockers, close the review.

Original languageItalian
Pages (from-to)544-553
Number of pages10
JournalRecenti Progressi in Medicina
Volume93
Issue number10
Publication statusPublished - Oct 2002

Fingerprint

Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Homeostasis
Angiotensin Receptor Antagonists
Diabetic Nephropathies
Peptidyl-Dipeptidase A
Hemostatics
Arterial Pressure
Heart Failure
Perfusion
Myocardial Infarction
Hypertension
Kidney
Therapeutics
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Il sistema renina-angiotensina-aldosterone, l'enzima di conversione dell'angiotensina I e gli ACE-inibitori. Prospettiva storica e recenti acquisizioni. / Gensini, Gian Franco; Lippi, Donatella; Conti, Andrea A.

In: Recenti Progressi in Medicina, Vol. 93, No. 10, 10.2002, p. 544-553.

Research output: Contribution to journalArticle

@article{f9c196a53bcd41a0a09f13b802a76984,
title = "Il sistema renina-angiotensina-aldosterone, l'enzima di conversione dell'angiotensina I e gli ACE-inibitori. Prospettiva storica e recenti acquisizioni",
abstract = "The renin-angiotensin-aldosterone system (RAAS) is committed to the regulation of circulatory homeostasis. This system, present in the majority of animal species, is constituted by several elements which behave as effectors able to increase their levels in response to the reduction of the intravascular volume and to the decrease of the renal perfusion. In turn, RAAS is regulated by a number of mechanisms. In our review a historical view precedes the description of the major functions of RAAS, i.e. the regulation of arterial pressure and the control of the hydroelectrolytic homeostasis. The evolution of the achievements about the angiotensin I converting enzyme is reviewed and the currently investigated relationship between RAAS and hemostatic system is assessed. The historical perspective of this review is useful to follow the key passages leading from clinical research to evidence-based therapeutic applications, in particular to the development of ACE-inhibitors. The evaluation of the rationale of ACE-inhibitors therapy in the treatment of arterial hypertension, acute myocardial infarction, heart failure, and diabetic nephropathy, and a discussion of the angiotensin receptor blockers, close the review.",
keywords = "ACE-inhibitors, Diabetic nephropathy, Evidence based medicine, History of medicine, Renin-angiotensin-aldosterone system",
author = "Gensini, {Gian Franco} and Donatella Lippi and Conti, {Andrea A.}",
year = "2002",
month = "10",
language = "Italian",
volume = "93",
pages = "544--553",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "10",

}

TY - JOUR

T1 - Il sistema renina-angiotensina-aldosterone, l'enzima di conversione dell'angiotensina I e gli ACE-inibitori. Prospettiva storica e recenti acquisizioni

AU - Gensini, Gian Franco

AU - Lippi, Donatella

AU - Conti, Andrea A.

PY - 2002/10

Y1 - 2002/10

N2 - The renin-angiotensin-aldosterone system (RAAS) is committed to the regulation of circulatory homeostasis. This system, present in the majority of animal species, is constituted by several elements which behave as effectors able to increase their levels in response to the reduction of the intravascular volume and to the decrease of the renal perfusion. In turn, RAAS is regulated by a number of mechanisms. In our review a historical view precedes the description of the major functions of RAAS, i.e. the regulation of arterial pressure and the control of the hydroelectrolytic homeostasis. The evolution of the achievements about the angiotensin I converting enzyme is reviewed and the currently investigated relationship between RAAS and hemostatic system is assessed. The historical perspective of this review is useful to follow the key passages leading from clinical research to evidence-based therapeutic applications, in particular to the development of ACE-inhibitors. The evaluation of the rationale of ACE-inhibitors therapy in the treatment of arterial hypertension, acute myocardial infarction, heart failure, and diabetic nephropathy, and a discussion of the angiotensin receptor blockers, close the review.

AB - The renin-angiotensin-aldosterone system (RAAS) is committed to the regulation of circulatory homeostasis. This system, present in the majority of animal species, is constituted by several elements which behave as effectors able to increase their levels in response to the reduction of the intravascular volume and to the decrease of the renal perfusion. In turn, RAAS is regulated by a number of mechanisms. In our review a historical view precedes the description of the major functions of RAAS, i.e. the regulation of arterial pressure and the control of the hydroelectrolytic homeostasis. The evolution of the achievements about the angiotensin I converting enzyme is reviewed and the currently investigated relationship between RAAS and hemostatic system is assessed. The historical perspective of this review is useful to follow the key passages leading from clinical research to evidence-based therapeutic applications, in particular to the development of ACE-inhibitors. The evaluation of the rationale of ACE-inhibitors therapy in the treatment of arterial hypertension, acute myocardial infarction, heart failure, and diabetic nephropathy, and a discussion of the angiotensin receptor blockers, close the review.

KW - ACE-inhibitors

KW - Diabetic nephropathy

KW - Evidence based medicine

KW - History of medicine

KW - Renin-angiotensin-aldosterone system

UR - http://www.scopus.com/inward/record.url?scp=0036785055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036785055&partnerID=8YFLogxK

M3 - Articolo

C2 - 12405014

AN - SCOPUS:0036785055

VL - 93

SP - 544

EP - 553

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 10

ER -